Brawn Biotech passes all resolutions at 41st AGM held virtually
- All four resolutions passed with requisite majority at the 41st AGM
- Meeting held virtually via VC/OAVM on September 29, 2026
- Brij Raj Gupta re-appointed as director retiring by rotation
- M/s. G D S M and Co. appointed as new Statutory Auditors
- Managerial remuneration for Mr. Amit Kumar approved under Companies Act, 2013
*this image is generated using AI for illustrative purposes only.
Brawn Biotech Ltd concluded its 41st Annual General Meeting on September 29, 2026, with all proposed resolutions passing through the requisite majority. The meeting was conducted entirely through Video Conferencing and Other Audio Visual Means (VC/OAVM).
The session commenced at 11:00 am and concluded ten minutes later at 11:10 am. Brij Raj Gupta served as the Chairman of the meeting. The company confirmed that the results were validated by a scrutinizer's report dated September 29, 2026.
Meeting details and compliance
The Annual General Meeting was convened in accordance with the notice issued on August 13, 2026. As per standard corporate governance practices, the detailed proceedings and voting results will be uploaded to the company's official website and submitted to the stock exchanges for public record.
Priyanka Sharma, Company Secretary and Compliance Officer, signed off on the communication to the Bombay Stock Exchange (BSE). The filing confirms that no physical venue was utilized for this annual gathering, reflecting continued adoption of digital shareholder engagement methods.
Resolutions passed at the meeting
The meeting addressed four ordinary resolutions covering financial statements, board composition, statutory auditors, and managerial remuneration. Members present through VC and other audio-visual means totaled 44. The scrutinizer for the voting process was Mr. Viney, Company Secretary in Practice.
| Resolution | Particulars | Type |
|---|---|---|
| 1 | To receive, consider and adopt the Audited Financial Statement for FY26, including Balance Sheet, P&L, Cash Flow, Board Report, and Auditors' Report | Ordinary |
| 2 | To appoint a director in place of Mr. Brij Raj Gupta (DIN: 00974969), who retires by rotation and offers himself for re-appointment | Ordinary |
| 3 | Appointment of M/s. G D S M and Co. Chartered Accountants (Firm Registration No. 034194N) as Statutory Auditors | Ordinary |
| 4 | To consider and approve managerial remuneration of Mr. Amit Kumar (Manager-KMP) as per Companies Act, 2013 | Ordinary |
The company noted that there were no qualifications in the Audit Report or Secretarial Audit Report, so these were not read aloud during the session. Nine shareholders registered as speakers, and questions raised were addressed by the Company Secretary.
Historical Stock Returns for Brawn Biotech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.96% | +3.65% | -6.26% | +7.67% | +17.48% | +8.98% |
How will the adoption of the FY26 audited financial statements influence Brawn Biotech's upcoming capital allocation strategy and dividend policy?
What specific strategic priorities or operational changes are expected under the continued leadership of Chairman Brij Raj Gupta following his re-appointment?
Will the appointment of M/s. G D S M and Co. as statutory auditors lead to any changes in the company's internal control frameworks or reporting transparency?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
